The foundation of the modern Indian pharmaceutical industry was laid in the early twentieth century, with the establishment of Bengal Chemical & Pharmaceutical Works in Kolkata in 1901. During the two World Wars, the industry received an impetus, although development under British rule remained limited and India continued to depend substantially on pharmaceutical supplies from the U.K., France and Germany.
Following the launch of planned economic development, the Indian pharmaceutical industry expanded considerably in terms of production capabilities and product diversity. The industry progressed from primarily processing imported bulk drugs into tablets, capsules and other formulations to developing capabilities for manufacturing basic drugs and pharmaceutical intermediates. Collaboration with established firms in the U.S.A., Italy and U.K. also supported the development of a wider range of pharmaceutical products.
Over time, increasing domestic production of raw materials and basic components strengthened India's pharmaceutical manufacturing base, including capabilities in synthetic drugs, sulpha-group medicines, anti-T.B. drugs, vitamins and intermediates. The report highlights the continuing growth in pharmaceutical demand and indicates substantial scope for additional manufacturing capacity to address the requirements of the country's large and growing population.
| Particulars | Cost |
|---|---|
| Land & Building (0.25 Acre) | Rs. 40 Lac |
| Plant & Machinery | Rs. 57 Lac |
| Working Capital for 2 Months | Rs. 58 Lac |
| Total Capital Investment | Rs. 1.66 Cr |
| Rate of Return | 64% |
| Break Even Point | 51% |
A pharmaceutical manufacturing project involves the planned production of medicines and pharmaceutical formulations using appropriate facilities, equipment, raw materials and quality systems.
Depending on the product range, manufacturing activities may include tablets, capsules, injections, syrups, liquids, lotions, creams, ointments and pastes. The report covers formulation methods, manufacturing processes, machinery requirements, raw-material suppliers and plant flow diagrams. A pharmaceutical facility also requires appropriate controls for hygiene, process consistency, quality testing, documentation, storage and handling of materials.
The report covers a broad range of pharmaceutical formulations, including tablets, capsules, injections, syrups, liquids, lotions, creams, ointments and dental paste.
The formulation section includes examples of products across different dosage forms, while separate manufacturing sections describe processes such as tablet making, liquid manufacture, capsule filling and sealing, lotion manufacture, and ointment and paste production. The report also includes machinery requirements and process flow diagrams intended to support understanding of the respective manufacturing operations.
The machinery required depends on the dosage forms and manufacturing processes selected for the pharmaceutical plant.
Equipment may include machinery for mixing, processing, filtration, filling, bottling, capsule filling and sealing, as well as equipment associated with tablet, lotion, ointment and paste production. The report contains dedicated sections on machinery requirements and suppliers of pharmaceutical plant machinery. In practice, equipment selection should also consider formulation characteristics, production scale, material compatibility, cleaning requirements, process control, quality assurance and applicable manufacturing standards.
The report discusses several raw materials and pharmaceutical ingredients used in different formulations.
The listed materials include gelatine, food colours, sodium sulphate, pine oil, glycerine, caustic soda, methylated spirit, aspirin, paracetamol tablets (PCM), papain powder, vitamin and thymol. The appropriate materials for a particular product depend on the formulation and manufacturing process. Pharmaceutical raw materials should be sourced according to the required specifications and subjected to suitable quality checks, documentation and controlled storage before being released for manufacturing.
Quality and compliance are essential because pharmaceutical products must consistently meet defined standards for identity, strength, quality and safety.
A manufacturing operation therefore requires controlled processes, suitable facilities and equipment, trained personnel, documented procedures, testing and appropriate records. The report specifically addresses institutionalizing quality and compliance excellence as well as operational excellence. These areas are important for maintaining consistent manufacturing performance, controlling contamination and variability, ensuring traceability and supporting the regulatory requirements applicable to the products and markets served.
Rainwater harvesting can be incorporated through systems designed to collect, filter, store or facilitate groundwater recharge using suitable site infrastructure.
The report covers surface runoff harvesting and rooftop rainwater harvesting, including components such as catchments, transportation arrangements, sand gravel filters, charcoal filters, PVC-pipe filters and sponge filters. It also describes approaches including direct storage, groundwater-aquifer recharge, bore-well recharge, recharge pits, recharge shafts, dug-well recharge, recharge trenches and percolation tanks. The appropriate system depends on site conditions, water requirements and the intended use of collected water.
The report includes project cost estimates covering land and building, plant and machinery, working capital, total capital investment, rate of return and break even point.
The report also provides an appendix covering plant economics, fixed capital, raw materials, salary and wages, utilities and overheads, total working capital, cost of production, annual turnover, resources for finance, instalments, depreciation, profit analysis and projected balance sheet information. These sections provide a structured basis for reviewing the project's financial and operational requirements without changing or recalculating the figures presented in the report.
Detailed Project Report (DPR) includes Present Market Position and Expected Future Demand, Technology, Manufacturing Process, Investment Opportunity, Plant Economics and Project Financials. comprehensive analysis from industry covering detailed reporting and evaluates the position of the industry by providing insights to the SWOT analysis of the industry.
Each report include Plant Capacity, requirement of Land & Building, Plant & Machinery, Flow Sheet Diagram, Raw Materials detail with suppliers list, Total Capital Investment along with detailed calculation on Rate of Return, Break-Even Analysis and Profitability Analysis. The report also provides a birds eye view of the global industry with details on projected market size and then progresses to evaluate the industry in detail.
We can prepare detailed project report on any industry as per your requirement.
We can also modify the project capacity and project cost as per your requirement. If you are planning to start a business, contact us today.
EIRI Board is a single destination for all the industry, company and country reports. We feature a large repository of latest industry reports, leading and niche company profiles, and market statistics prepared by highly qualified consultants and verified by a panel of experts.
Note: We can also prepare project report on any subject based on your requirement and country. If you need, we can modify the project capacity and project cost based on your requirement.
Our reports provide an expansive market analysis of the sector by covering areas like growth drivers, trends prevailing in the industry as well as comprehensive SWOT analysis of the sector.
Speak with our experts and get personalized guidance for your manufacturing business idea, project planning, machinery selection, and investment strategy.